Skip to main content

Advertisement

Table 1 Characteristics of study participants (mean ± standard error)

From: The metabolic cost of lowering blood pressure with hydrochlorothiazide

  HCTZ Valsartan
Variable Baseline End Baseline End
N 6   9  
Male, % 71   22  
Age, years 35 ± 11   37 ± 5  
Hip circumference, cm 110 ± 6 115 ± 9 116 ± 10 116 ± 10
Waist circumference, cm 101 ± 12 104 ± 16 107 ± 9 107 ± 11
BMI, kg/m2 30.7 ± 2.4 31.6 ± 2.7 34.7 ± 3.4 34.9 ± 3.9
SBP, mmHg 120 ± 11 119 ± 9 114 ± 8 108 ± 9
DBP, mmHg 72 ± 8 71 ± 5 71 ± 7 67 ± 5
HR, beat/min 74 ± 9 77 ± 8 80 ± 7 81 ± 7
Glucose, mg/dL 95 ± 11 98 ± 11 100 ± 10 94 ± 11
Insulin, /mL 7 ± 6 8 ± 4 7 ± 5 9 ± 7
Cholesterol, mg/dL 209 ± 17 217 ± 34 194 ± 40 192 ± 30
Triglycerides, mg/dL 182 ± 118 186 ± 52 153 ± 106 151 ± 83
HDL, mg/dL 40 ± 8 41 ± 6 47 ± 14 49 ± 20
LDL, mg/dL 142 ± 17 139 ± 32 119 ± 31 113 ± 27
HbA1c, % 5.4 ± 0.1 55 ± 0.3 5.4 ± 0.5 55 ± 0.3
ALT, u/L 31 ± 8 31 ± 12 27 ± 25 22 ± 15
AST, u/L 29 ± 8 26 ± 6 21 ± 11 19 ± 6